It appears
that Continuing Education (CE) is on the way out in the UK. Continuing
Professional Development (CPD) is now in vogue and moves are afoot to
make this mandatory for UK pharmacists, who wish to remain on the register.
CE is only a part of the new CPD process.
The whole process as described in the Pharmaceutical Journal (UK) published
last week, seems to be a quality initiative, based around pharmacists
deciding what areas they need to improve, and undertaking the necessary
training and CE to meet these goals, and then evaluating the process.
The CE programs in the UK are now being rejigged to fit the CPD process,
and the various post-graduate Pharmacy education institutions are designing
their own CPD programs for pharmacists.
Large pharmacy chains will be forced to take a vested interest in providing
CPD opportunities to their pharmacists, particularly in the competitive
labour market that exists in the UK at the moment.
So how does this compare to the Australian situation?
In Queensland the new Pharmacists' Registration Act (2000) gives the
Board wide-scoping powers to implement such a scheme without needing
further legislation before the parliament.
And similar noises are coming from the other states.
So far only CE is really in place in Australia, and this was a requirement
during my pre-registration year, and was not too onerous a task.
I certainly feel it has helped to fill some gaps in my knowledge, and
in many instances replace knowledge I learnt only 12 months earlier.
The quality cycle of CPD is something which will not be foreign to many
pharmacists who will have been through the Quality Care program, although
it will be geared at pharmacists rather than pharmacies.
If we see the ideas from the UK filtering through to Australia it would
not be unreasonable to suggest that CPD will vary greatly depending
on the professional setting of the pharmacist.
Currently most CE is fairly general in nature, with the exception of
some hospital specific, and management specific training. CPD programs
will need the flexibility to be tailored to individual pharmacists if
they are going to be made mandatory. In a profession with a huge personnel
shortage, the last thing we need is requirements which are so demanding
they remove the initiative for older pharmacists to stay in the profession,
and which drive pharmacists away at the other end.
In the UK, it is thought that pharmacists who are changing their area
of practice will be the first targets of CPD.
This group seems an obvious target, and in Australia at the moment there
is a barrier between community and hospital pharmacy, that makes it
difficult for entrenched retail pharmacists to move into the clinical
setting (and vice-versa). The medication review accreditation process
will help with the necessary skills for pharmacists looking for clinical
work, but there is a knowledge gulf (which goes both ways) between the
two settings, and CPD may be one way of assisting pharmacists looking
to move between fields.
On a micro-level CPD could be targetted at clinical pharmacists changing
specialities, or retail pharmacists who are taking on more management
responsibilities, or the DMMR programme.
Not all in the UK believe mandatory CPD is the way to go, and the deputy
director of the Welsh equivalent of our ACPP is quoted in the above
article as saying "If you can demonstrate that the profession is doing
what it should do, you divert away the gaze of the Government.", implying
that it is little more than a smokescreen to appease the regulatory
bodies.
Another argument oft-used against compulsary CE or CPD is that it forces
uninterested parties to take part, and thus many activities are of little
value, and resources are wasted.
Thus there exists a challenge for those proposing compulsary CPD.
It has to be made relevant and interesting, so that pharmacists feel
a need to participate.
There is an obvious benefit that can be gained for the profession as
a whole from ensuring all pharmacists are engaged in personal quality
improvement (as ghastly as the terminology may be!).
The Pharmaceutical Journal (UK) article: http://www.pharmj.com/Editorial/20011027/features/cpd.html
Ends
Back
to Article Index
Newsletter
Reader's Forum
Previous Article
|
Next Article
|
The
comments and views expressed in the above article are those of
the author and no other. The author welcomes any comment and interaction,
directly or via the Newsletter Reader's Forum.
|
The
newsletter archives are now fully searchable via the search engine
on the left hand side of this page. If you would like to find
similar articles to the above material, please enter the appropriate
keyword(s). To retain context with multiple keywords or phrases,
please enclose in inverted commas.
|
*
Please contact us if you would like further information or would
like us to research additional material to publish as future articles.
|
*
Don't forget to advise of any change in your e-mail address so that
your subscription may be continued without interruption.
|
*
Letters to the editor are encouraged, or if you have material you
would like published, please forward to the editor.
|
*
Any interested persons who would like to receive this free newsletter
on their desktop each fortnight, please send a single word e-mail
"Subscribe"
|
*
If you have found value in this newsletter, please share it with
a friend, or alternatively, encourage a colleague to subscribe
|
|
*
You are invited to visit the Computachem web site and check out
an organised reference site for medical or other references.
Why not try (and bookmark) the
Computachem Interweb Directory
for an easily accessed range of medical and
pharmacy links, plus a host of pharmacy relevant links.
The directory also contains a very fast search engine for Internet
enquiries. You may also access the Home Page at:
http://www.computachem.com.au
|
|